ENCISION INC — SEC Form D Filing
ENCISION INC filed an SEC Form D on September 17, 2026, reporting $80K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 17, 2026
- Amount reported
- $80K
- Round stage
- Series B+
- Industry
- Medical Devices
- Website
- https://www.encision.com/
What the company does
Securities: Equity. Revenue: $5,000,001 - $25,000,000. Exemption: Rule 506(b). Incorporated: COLORADO
Problem
During monopolar laparoscopic surgery, patients face a significant risk of unintended burns from intra-operative insulation failure and capacitive coupling, with these preventable stray energy burns occurring frequently and leading to patient deaths.
Solution
Encision provides AEM® Shield™ Laparoscopic Instruments and AEM enTouch® Reposable 2x Scissors which actively monitor and shield against insulation failure and capacitive coupling to eliminate these complications and improve patient safety during surgery.
Why now
Regulatory bodies like the FDA have issued safety communications on the dangers of monopolar laparoscopic surgery, and organizations like AORN have updated guidelines recommending AEM and shielding devices, creating a strong market demand for safer surgical instruments.
Verdict
This cleared because it offered a tangible solution to a regulated, high-stakes patient safety problem with existing guidelines creating immediate demand, not because it promised a disruptive shift in surgical practice. Investors were implicitly betting on rapid adoption within hospital systems driven by risk mitigation and regulatory compliance, where the cost of the device was minor compared to the cost of adverse events. The upside was limited by the specialized application within monopolar laparoscopic surgery and the strong incumbent presence requiring direct displacement rather than market expansion.
Source: SEC EDGAR Form D filing